US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about PDUFA Date

Recent news which mentions PDUFA Date

U.S. FDA And European Medicines Agency Accepted Pfizer's Hair Loss Candidate Submission For Review
Tickers PFE
Tags Market News Health Care Biotech
From Benzinga
FDA Accepts Krystal Biotech's Filing For Genetic Skin Disorder Candidate Under Priority Review
Tickers KRYS
Tags News FDA KRYS
From Benzinga
FDA Accepts Acer's Inborn Metabolism Disorder Therapy Refiling For Review
Tickers ACER
Tags General PDUFA Date Benzinga
From Benzinga
FDA Accepts Lexicon's New Drug Application For Review In Heart Failure Setting
Tickers LXRX
Tags LXRX Market News Biotech
From Benzinga
Coherus's Refiling For Head and Neck Cancer Candidate Accepted By FDA For Review
Tickers CHRS
Tags CHRS Health Care Market News
From Benzinga
U.S. FDA Accepts Emergent's Anthrax Vaccine Candidate Filing For Review
Tickers EBS
Tags EBS Biotech Market News
From Benzinga